Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum IgG antibodies to human herpesvirus-6 (HHV-6) do not predict the progression of HIV disease to AIDS. Italian Seroconversion Study group.
Dorrucci M, Rezza G, Andreoni M, Pezzotti P, Nicastri E, Ventura L, Zignani M, Alliegro MB, Tarantini G, Salassa B, Colangeli V, Mazzarello G, Ursitti MA, Barbanera M, Pristerà R, Castelli F, Ortona L. Dorrucci M, et al. Among authors: ortona l. Eur J Epidemiol. 1999 Apr;15(4):317-22. doi: 10.1023/a:1007503018729. Eur J Epidemiol. 1999. PMID: 10414371
Phase II controlled trial of post-exposure immunization with recombinant gp160 versus antiretroviral therapy in asymptomatic HIV-1-infected adults. VaxSyn Protocol Team.
Pontesilli O, Guerra EC, Ammassari A, Tomino C, Carlesimo M, Antinori A, Tamburrini E, Prozzo A, Seeber AC, Vella S, Ortona L, Aiuti F. Pontesilli O, et al. Among authors: ortona l. AIDS. 1998 Mar 26;12(5):473-80. doi: 10.1097/00002030-199805000-00008. AIDS. 1998. PMID: 9543445 Clinical Trial.
Risk of developing AIDS in newly seropositive intravenous drug abusers.
Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristerà R, Ortona L, Barbanera M, Salassa B, Tirelli U, Aiuti F, et al. Rezza G, et al. Among authors: ortona l. J Infect Dis. 1989 Jun;159(6):1156. doi: 10.1093/infdis/159.6.1156. J Infect Dis. 1989. PMID: 2656884 Clinical Trial. No abstract available.
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C, Pezzotti P, Govoni A, Borghi V, Antinori A, d'Arminio Monforte A, De Luca A, Mongiardo N, Cerri MC, Chiodo F, Concia E, Bonazzi L, Moroni M, Ortona L, Esposito R, Cossarizza A, De Rienzo B. Mussini C, et al. Among authors: ortona l. J Infect Dis. 2000 May;181(5):1635-42. doi: 10.1086/315471. Epub 2000 May 15. J Infect Dis. 2000. PMID: 10823763 Clinical Trial.
Changing disease patterns in focal brain lesion-causing disorders in AIDS.
Ammassari A, Scoppettuolo G, Murri R, Pezzotti P, Cingolani A, Del Borgo C, De Luca A, Antinori A, Ortona L. Ammassari A, et al. Among authors: ortona l. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1;18(4):365-71. doi: 10.1097/00042560-199808010-00008. J Acquir Immune Defic Syndr Hum Retrovirol. 1998. PMID: 9704942
171 results